IPO registrations (S-1, F-1) · Registrants
Vitro Biopharma, Inc.
- SEC CIK
- 793171 · filings on EDGAR ↗
- Former names
- VITRO DIAGNOSTICS INC (1996–2021)
- Registration
- Form S-1, first filed 2022-09-09, last 2024-09-05; 1 initial registration, 12 amendments
- Outcome
- Declared effective 2024-09-11
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- NV
- Business address
- 3200 CHERRY CREEK DRIVE SOUTH, SUITE 410, Denver, CO 80209
- EIN
- 84-1012042
- EDGAR entity type
- operating
- Insiders and CEO pay
- Vitro Biopharma, Inc. on the corporate pages
Offering terms
- Proposed price range
- $5.00–$6.00 per share (S-1/A filed 2024-09-05)
- Shares offered
- 1,000,000
- Listing
- NYSE American under the symbol VTRO
- Lead underwriters
- Dominari Securities
- Syndicate
- RBW Capital; of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: VITRO BIOPHARMA, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: VITRO DIAGNOSTICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: VITRO BIOPHARMA, INC. Fuzzy (name and state)
- Form D issuer: Vitro Biopharma, Inc. EXACT (CIK (EXACT))
- SEC filer: Vitro Biopharma, Inc. EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-09-09 | S-1 | S-1 (registration) | Vitro Biopharma, Inc. | 0001493152-22-025515 ↗ |
| 2022-11-03 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-22-030380 ↗ |
| 2023-05-08 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-015832 ↗ |
| 2023-06-02 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-020018 ↗ |
| 2023-06-29 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-022972 ↗ |
| 2023-07-17 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-024669 ↗ |
| 2023-08-29 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-030408 ↗ |
| 2023-12-12 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-23-044572 ↗ |
| 2024-02-02 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-24-004779 ↗ |
| 2024-07-01 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-24-025754 ↗ |
| 2024-08-08 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-24-030726 ↗ |
| 2024-08-23 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-24-033726 ↗ |
| 2024-09-05 | S-1/A | S-1/A (amendment) | Vitro Biopharma, Inc. | 0001493152-24-035112 ↗ |
| 2024-09-11 | EFFECT | EFFECT (declared effective) | Vitro Biopharma, Inc. | 9999999995-24-002788 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-05 | S-1/A | registration statement | $5.00–$6.00 | 1,000,000 | - | NYSE American VTRO | 3 | primary document; range, shares headline, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| James R Musick Trust | Director,Officer,TenPercentOwner; TenPercentOwner | Pres / CEO | 4 | 2006–2022 | |
| MUSICK JAMES R | Director,Officer,TenPercentOwner | Chief Science Officer; Pres & CEO; President, CEO; President/CEO | 5 | 2006–2022 | |
| Gibbs John D | TenPercentOwner | 3 | 2008–2009 | ||
| VAN HORN ERIK | Director | 2 | 2009–2011 | ||
| SHUSTER PETE | Director | 4 | 2014 | ||
| Liter Jeffrey Scott | Director | 1 | 2014 | ||
| Evans John | Director,Officer | CFO | 1 | 2017 | |
| Furman Christopher | Director,Officer | Chief Executive Officer | 2 | 2022–2023 | |
| Haas Nathan | Officer | Chief Financial Officer | 1 | 2022 | |
| Mosessian Caroline | Director,Officer | Chair of the Board, CRO | 1 | 2022 | |
| Packs John | Director | 1 | 2022 | ||
| Zamora Jack | Director,TenPercentOwner | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-06-11 | Vitro Biopharma, Inc. | Biotechnology | $15,000,000 | $100,000 | 1 | 1 |
| 2023-12-01 | Vitro Biopharma, Inc. | Biotechnology | $3,000,000 | $2,000,000 | 1 | 1 |
| 2023-01-23 | Vitro Biopharma, Inc. | Biotechnology | $2,500,000 | $992,600 | 9 | 2 |
| 2021-10-20 | VITRO DIAGNOSTICS INC | Biotechnology | $10,000,000 | $3,000,000 | 1 | 1 |
| 2020-01-23 | VITRO DIAGNOSTICS INC | Biotechnology | $3,500,000 | $1,000,000 | 10 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | VITRO BIOPHARMA, INC. | CO | State business registries | name and state |
| Plan sponsor | VITRO DIAGNOSTICS, INC. | CO | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | VITRO BIOPHARMA, INC. | CO | Federal spending (USAspending) | name and state |
| Form D issuer | Vitro Biopharma, Inc. | CO | Form D private offerings | CIK (EXACT) |
| SEC filer | Vitro Biopharma, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Vitro Biopharma, Inc. | CO | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | VITRO DIAGNOSTICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), CO first:
- ACESIS HOLDINGS CORP. CO
- Fresh Tracks Therapeutics, Inc. CO
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
- MESOBLAST LTD C3
- Ablynx NV C9
In other datasets, the same topic (Health) in CO:
- Nonprofit: 3 4 FIGHTING PARKINSONS (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health